NCT00637871View on ClinicalTrials.gov

Casodex - Nolvadex Combination

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2005

Conditions
GynaecomastiaProstate Cancer
Interventions
DRUG

Casodex

150mg once daily

DRUG

Tamoxifen

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00637871 - Casodex - Nolvadex Combination | Biotech Hunter | Biotech Hunter